San Francisco

If you purchased FEI or TRIBE tokens in the Genesis Event between March 31, 2021 and April 3, 2021, a class action settlement may affect your rights

Retrieved on: 
Friday, July 7, 2023
San Francisco, ETH, Superior court, Tax, Genesis, Negotiation, Lawyer, Person, Sale, Documentation, Notice, Burnham v. Superior Court of California, Hearing, Court, Post office box, Plaintiff, FEI, Cryptocurrency, Pharmaceutical industry, Insurance

COSTA MESA, Calif., July 7, 2023 /PRNewswire/ -- Simpluris Inc. announces that a settlement has been proposed in a class action lawsuit concerning the sale of "FEI" or "TRIBE" tokens through the Fei Protocol in an initial sale conducted between March 31, 2021 and April 3, 2021, called the "Genesis Event." The settlement will provide $17,850,000.00 to pay claims to persons and entities who purchased FEI or TRIBE tokens in the Genesis Event. If you qualify, you can submit a Proof of Claim form to get your share of the settlement, exclude yourself from the settlement to retain your right to sue, or object to the settlement. The amount of your claim could be substantial.

Key Points: 
  • The settlement will provide $17,850,000.00 to pay claims to persons and entities who purchased FEI or TRIBE tokens in the Genesis Event.
  • Before any money is paid, the Court will have a hearing to decide whether to approve the settlement.
  • The lawsuit claims that the sale of FEI and TRIBE tokens in the Genesis Event was a sale of unregistered securities.
  • The plaintiff claims that this entitles persons who purchased FEI and TRIBE tokens directly from the Fei Protocol in the Genesis Event to get compensation.

If you purchased FEI or TRIBE tokens in the Genesis Event between March 31, 2021 and April 3, 2021, a class action settlement may affect your rights

Retrieved on: 
Friday, July 7, 2023
San Francisco, ETH, Superior court, Tax, Genesis, Negotiation, Lawyer, Person, Sale, Documentation, Notice, Burnham v. Superior Court of California, Hearing, Court, Post office box, Plaintiff, FEI, Cryptocurrency, Pharmaceutical industry, Insurance

COSTA MESA, Calif., July 7, 2023 /PRNewswire/ -- Simpluris Inc. announces that a settlement has been proposed in a class action lawsuit concerning the sale of "FEI" or "TRIBE" tokens through the Fei Protocol in an initial sale conducted between March 31, 2021 and April 3, 2021, called the "Genesis Event." The settlement will provide $17,850,000.00 to pay claims to persons and entities who purchased FEI or TRIBE tokens in the Genesis Event. If you qualify, you can submit a Proof of Claim form to get your share of the settlement, exclude yourself from the settlement to retain your right to sue, or object to the settlement. The amount of your claim could be substantial.

Key Points: 
  • The settlement will provide $17,850,000.00 to pay claims to persons and entities who purchased FEI or TRIBE tokens in the Genesis Event.
  • Before any money is paid, the Court will have a hearing to decide whether to approve the settlement.
  • The lawsuit claims that the sale of FEI and TRIBE tokens in the Genesis Event was a sale of unregistered securities.
  • The plaintiff claims that this entitles persons who purchased FEI and TRIBE tokens directly from the Fei Protocol in the Genesis Event to get compensation.

SENTINEL RESOURCE GROUP TAPS FORMER PROSECUTOR AND SAN JOSE POLICE INTELLIGENCE CENTER LEADER AS FIRST LEGAL CHIEF

Retrieved on: 
Friday, July 7, 2023
Sentinel, San Francisco, Santa Clara University School of Law, San Francisco District Attorney's Office, CLO, State Bar of California, Intelligence, Bar association, United States Department of Justice Criminal Division, SAN, Private investigator, Management, Salvatore Carrubba, SRG

SAN JOSE, Calif., July 7, 2023 /PRNewswire/ -- Sentinel Resource Group (SRG) announces the strategic hire of Frank Carrubba as its first Chief Legal Officer.

Key Points: 
  • SAN JOSE, Calif., July 7, 2023 /PRNewswire/ -- Sentinel Resource Group (SRG) announces the strategic hire of Frank Carrubba as its first Chief Legal Officer.
  • Carrubba, an accomplished legal and intelligence professional, recently led the San Jose Police Criminal Data Intelligence Center, established by now Dallas Chief of Police Eddie Garcia.
  • Known for his innovation in shaping law enforcement intelligence capabilities, Carrubba has a proven record in the design, development, and optimization of intelligence fusion centers.
  • Before this, Carrubba enjoyed a 25-year career as a prosecutor with the Santa Clara County District Attorney's Office.

The New CEO of ABVC BioPharma Takes Steps to Help Improve Cash Efficiency

Retrieved on: 
Thursday, July 6, 2023
San Francisco, University, Non-small-cell lung cancer, ADHD, NSCLC, Attention deficit hyperactivity disorder, CNS, DSM-IV codes, MDD, UCSF, Ophthalmology, Growth, Phase, FDA, IND, US FDA, Medical device, Pharmaceutical industry, Polaris

Uttam Patil, Ph.D., Chief Executive Officer of ABVC , expressed great confidence in the Company's diverse product pipeline, which spans multiple subsidiaries.

Key Points: 
  • Uttam Patil, Ph.D., Chief Executive Officer of ABVC , expressed great confidence in the Company's diverse product pipeline, which spans multiple subsidiaries.
  • This strategic decision fosters a sense of ownership, enables capital to be focused on clinical programs, and enhances equity within the Company.
  • As ABVC looks towards the future, "Investors need to have comfort that Dr. Patil is going to be dialed in as the new CEO of ABVC for the better part of the next decade," agreed ABVC's Board of Directors.
  • The board understands Dr. Patil's foresight about the Company's potential, with a steadfast commitment to reinvesting profits for business expansion.

VyncaCare Names Darren Schulte, MD, Chief Executive Officer, and James P. Bradley, Board Chairman

Retrieved on: 
Wednesday, June 28, 2023
San Francisco, NCQA, University, Risk-adjusted return on capital, Internal medicine, Stanford University, Harvard University, The Advisory Board Company, McKesson Corporation, Ageing, Humana, Committee, Advanced technology, National Committee, Bradley, Centene Corporation, Acquisition, UnitedHealth Group, Patient, Risk, SAN, Berkeley, Quality assurance, Performance measurement, Growth, Surescripts, National Committee for Quality Assurance, Management, Nursing, Medical device, MD

SAN FRANCISCO, June 28, 2023 /PRNewswire/ -- VyncaCare, a serious illness management company, announced the appointment of Darren Schulte, MD, as the Chief Executive Officer and Board Director and James P. Bradley as Chairman of the Board of Directors. Dr. Schulte succeeds co-founder Ryan Van Wert, MD, who steps down after a decade of leading VyncaCare.

Key Points: 
  • SAN FRANCISCO, June 28, 2023 /PRNewswire/ -- VyncaCare , a serious illness management company, announced the appointment of Darren Schulte, MD, as the Chief Executive Officer and Board Director and James P. Bradley as Chairman of the Board of Directors.
  • The newly appointed Board Chairman, James P. Bradley, is an accomplished technologist, entrepreneur, and board leader whose career spans the healthcare industry.
  • "I am delighted to join the outstanding VyncaCare team and the Board at this time in their journey," said Mr. Bradley.
  • I look forward to collaborating with Darren and the team to guide VyncaCare as it serves a much larger patient population nationwide."

Developing Next-Gen Scientific Leaders: The Parker Institute for Cancer Immunotherapy Awards up to $2.9 Million to Eight Early Career Investigators

Retrieved on: 
Tuesday, June 27, 2023
Research, Hospitals, Health Technology, Biotechnology, Health, Pharmaceutical, General Health, Science, Oncology, San Francisco, Computational biology, University, Freedom, Systems biology, Neoplasm, University of California, San Francisco, Cancer, Multimedia, Mount Sinai, Cell, Immunotherapy, Doctor of Philosophy, Icahn School of Medicine at Mount Sinai, B cell, CAR, MD, Patient, Immune system, Stanford University School of Medicine, Escape Room, Faculty, Gladstone Institutes, Tumor microenvironment, Parker Bridge, Metastasis, Prostate cancer, Pharmaceutical industry, Nursing, Vaccine, Management, Medical imaging, Stanford University, Medicine

​Powered by a commitment to accelerating bold, emerging science, the Parker Institute for Cancer Immunotherapy (PICI) continues to invest in the next generation of scientific leaders and their ambitious ideas for curative cancer treatments.

Key Points: 
  • ​Powered by a commitment to accelerating bold, emerging science, the Parker Institute for Cancer Immunotherapy (PICI) continues to invest in the next generation of scientific leaders and their ambitious ideas for curative cancer treatments.
  • “Not only do we invest in today’s preeminent scientists, we also empower the cancer immunotherapy leaders of tomorrow,” said John Connolly, PhD, Chief Scientific Officer at PICI.
  • Rounding out this year’s class are five Parker Scholars, scientists who are ready to establish a laboratory or independent program in cancer immunotherapy.
  • Early career researchers also have access to leading-edge technology and other top collaborators to further guide and propel research.

Berkeley SkyDeck to Host 30 Japanese Startups Through JETRO Partnership

Retrieved on: 
Tuesday, June 27, 2023
Start-Up, Other Education, Professional Services, University, Education, San Francisco, Partnership, Japan External Trade Organization, JETRO, Multimedia, Mentorship, Government, Organization, Entrepreneurship, Acquisition, Berkeley SkyDeck, Ecosystem, Video game, SkyDeck, Silicon

Berkeley SkyDeck , the global hub for entrepreneurship and a leading accelerator, today announced a significant expansion of its partnership with the Japan External Trade Organization (JETRO) resulting in 30 Japanese startups being selected to participate in Berkeley SkyDeck’s Batch 17 Innovation Partner Program in November.

Key Points: 
  • Berkeley SkyDeck , the global hub for entrepreneurship and a leading accelerator, today announced a significant expansion of its partnership with the Japan External Trade Organization (JETRO) resulting in 30 Japanese startups being selected to participate in Berkeley SkyDeck’s Batch 17 Innovation Partner Program in November.
  • All 30 startups will receive access to Berkeley SkyDeck’s vast network of resources, mentors, and investors as they plan to break into the US market.
  • Startups are sent to Berkeley SkyDeck by SkyDeck Innovation Partners, which are usually government organizations from outside of the US such as JETRO.
  • Through this program, SkyDeck Innovation Partners are plugged into the Berkeley SkyDeck ecosystem, and the startups are able to access the significant network, advisor insights, and other resources SkyDeck has to offer.

SandboxAQ Announces Bio-Pharma Molecular Simulation Division to Speed Life-Saving Drugs to Patients Through AI and Quantum Solutions

Retrieved on: 
Saturday, June 24, 2023
DMRG, San Francisco, TPU, Partnership, Post, PALO, Columbia University Irving Medical Center, Ligand, Pulitzer Prize, University of California, San Francisco, Cancer, Research, AstraZeneca, Drug design, AQ, DFT, Alzheimer's disease, Pulitzer, Parkinson's disease, UC, MD, UCSF, Patient, Drug discovery, Sanofi, Neurodegenerative disease, AI, Fine chemical, Pharmaceutical industry, Medical device

PALO ALTO, Calif., June 23, 2023 /PRNewswire-PRWeb/ --  After several years of stealth development, SandboxAQ today formally announced its bio-pharma molecular simulation division, AQBioSim, and some of its customers and partners. The division is helping bio-pharma and research institutions achieve breakthroughs in treatments for cancer, Alzheimer's, Parkinson's, and other conditions. The company is collaborating with a range of bio-pharma companies and university research labs, including AstraZeneca, Sanofi and UC San Francisco.

Key Points: 
  • The division is helping bio-pharma and research institutions achieve breakthroughs in treatments for cancer, Alzheimer's, Parkinson's, and other conditions.
  • Paul Hudson, CEO of Sanofi said, "We are very interested in the work SandboxAQ is doing to revolutionize drug discovery and development via in-silico simulation of molecular interactions using AI and quantum technologies.
  • "SandboxAQ is at the forefront of combining AI and quantum techniques to address large, enterprise challenges.
  • SandboxAQ's technology is revolutionizing the drug discovery and development process," said Eric Schmidt, Chairman of the Board of SandboxAQ."

hoopla Digital Launches New Manga Experience

Retrieved on: 
Wednesday, June 21, 2023
Dark, Titan, San Francisco, Titan Publishing Group, Heart, Udon Entertainment, Partnership, San Francisco Public Library, Chicago Public Library, Path of the Assassin, Android, Los Angeles Public Library, Marketing, Dark Horse Comics, IOS, Creativity, Digital, Library, Assassination, Librarian, Ebook, Publishing, Entertainment, Book, Fantagraphics

HOLLAND, Ohio, June 21, 2023 /PRNewswire/ -- hoopla Digital, the only all-in-one app for public libraries, is strengthening its leadership of the comics category among library digital platforms with the launch of its new manga offering.

Key Points: 
  • HOLLAND, Ohio, June 21, 2023 /PRNewswire/ -- hoopla Digital, the only all-in-one app for public libraries, is strengthening its leadership of the comics category among library digital platforms with the launch of its new manga offering.
  • Patrons of libraries that partner with hoopla can immediately access manga content for all ages and reading abilities.
  • Understanding the importance of this experience, hoopla has updated its exclusive ActionView functionality to allow readers to be fully immersed in the action in the traditional order.
  • "Those who tap into our manga offering will see the deep respect and appreciation we have for manga creators."

Internationally Renowned Expert and San Francisco Bay University Professor Ahmed Banafa Releases Two Books on Blockchain Technology and Internet of Things

Retrieved on: 
Tuesday, June 20, 2023
San Francisco, Blockchain, BBC, Internet of things, Research, Multimedia, CBS, NBC, CNN, Human voice, MIT Technology Review, Fox Broadcasting Company, Internet, IEEE, Engineering, San Francisco Bay, ABC, NPR, Book, Cryptocurrency

FREMONT, Calif., June 20, 2023 /PRNewswire/ -- Ahmed Banafa, a globally recognized expert and professor at San Francisco Bay University, is set to release two insightful books, "Introduction to Blockchain Technology" and "Introduction to Internet of Things" on July 28 and July 31, 2023, respectively.

Key Points: 
  • FREMONT, Calif., June 20, 2023 /PRNewswire/ -- Ahmed Banafa, a globally recognized expert and professor at San Francisco Bay University, is set to release two insightful books, "Introduction to Blockchain Technology" and "Introduction to Internet of Things" on July 28 and July 31, 2023, respectively.
    "
  • Introduction to Blockchain Technology " delves into the fundamentals of blockchain, a transformative technology with significant potential in various sectors such as banking and supply chain. "
  • Introduction to Internet of Things " provides a comprehensive overview of IoT, a technology set to interconnect up to 75 billion devices by 2025, transforming our lives and businesses.
  • Professor Banafa shared, "With these books, I aim to guide readers through these revolutionary technologies that are shaping our future.